SUPN SUPERNUS PHARMACEUTICALS INC

Ownership history in Point72 (DIFC) Ltd  ·  4 quarters on record

This page tracks every 13F SEC filing in which Point72 (DIFC) Ltd reported a position in SUPERNUS PHARMACEUTICALS INC (SUPN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q2 REDUCED 934 -2,140 -69.6% 0.00% $29K $31.52
2025 Q1 ADDED 3,074 +2,619 +575.6% 0.00% $101K $32.75
2024 Q3 REDUCED 455 -3,746 -89.2% 0.00% $14K $31.18
2024 Q1 INITIATED 4,201 0.00% $143K
% of Fund (quarterly)    SUPN price (monthly, adj. close)
← Back to Point72 (DIFC) Ltd Holdings